# Bioimpedance Integration for Optimized Fluid Management in Decompensated Heart Failure

Study · id `cardio:ct-nct07173426` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07173426](<https://clinicaltrials.gov/study/NCT07173426>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07173426

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 255 participants.

## Technical summary

Registry record NCT07173426. Randomized; single masking; primary purpose treatment. Start 2024-12-30 (actual); primary completion 2026-05-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 255 participants (planned count; ClinicalTrials.gov record NCT07173426, source copy `cardio:ctgov-nct07173426-2025-09-15`, retrieved 2026-10-26)
- Started: 2024-12-30 (actual) (ClinicalTrials.gov record NCT07173426, source copy `cardio:ctgov-nct07173426-2025-09-15`, retrieved 2026-10-26)
- Primary completion: 2026-05-01 (anticipated) (ClinicalTrials.gov record NCT07173426, source copy `cardio:ctgov-nct07173426-2025-09-15`, retrieved 2026-10-26)
- Completion: 2026-12-01 (anticipated) (ClinicalTrials.gov record NCT07173426, source copy `cardio:ctgov-nct07173426-2025-09-15`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT07173426, source copy `cardio:ctgov-nct07173426-2025-09-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07173426-2025-09-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Bioimpedance Integration for Optimized Fluid Management in Decompensated Heart Failure
- Acronym: BIO-HF
- Condition: Heart Failure
- Condition: Decompensated Heart Failure
- Intervention (Device): Bioimpedance analysis
- Lead sponsor: Mid and South Essex NHS Foundation Trust
- Lead sponsor class: OTHER
- Collaborator: Anglia Ruskin University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Mid and South Essex NHS Foundation Trust (`cardio:org-mid-and-south-essex-nhs-foundation-trust`)

## Provenance

Content hash: 2760ca798bc66f13587c783e989c5958261c98feacc83100553728901b1e14b6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
